Iron Metabolism as a Potential Mechanism for Inducing TRAIL-Mediated Extrinsic Apoptosis Using Methylsulfonylmethane

Nipin Sp1, Dong Young Kang1, Eun Seong Jo2

  • 1Department of Pathology, Institute of Biomedical Science and Technology, School of Medicine, Konkuk University, Chungju 27478, Korea.

Cells
|November 27, 2021
PubMed

Insights

Methylsulfonylmethane (MSM) targets embryonic cancer stem cells (CSCs) by inhibiting iron metabolism, inducing TRAIL-mediated apoptosis. This natural compound shows promise for neoadjuvant therapy by suppressing CSCs and reducing cancer recurrence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Embryonic cancer stem cells (CSCs) possess the potential to differentiate into various cancer types, contributing to tumor recurrence.
  • Natural compounds offer a promising avenue for targeting CSCs with reduced adverse effects.
  • Methylsulfonylmethane (MSM), a sulfur-containing compound, exhibits known anticancer properties.

Purpose of the Study:

  • To elucidate the mechanistic anticancer effects of methylsulfonylmethane (MSM) on embryonic cancer stem cells (CSCs).
  • To investigate MSM's impact on CSC markers and associated signaling pathways.
  • To determine the specific apoptotic pathway induced by MSM in cancer cells.

Main Methods:

  • Western blotting and real-time quantitative PCR (qPCR) were employed for molecular signaling analysis.
  • Flow cytometry was utilized to analyze cellular processes.
  • Specific CSC markers, Wnt/β-catenin signaling, and apoptosis pathways were assessed.

Main Results:

  • MSM significantly inhibited the expression of CSC markers and suppressed Wnt/β-catenin signaling.
  • MSM induced TRAIL-mediated extrinsic apoptosis in NCCIT and NTERA-2 cells, bypassing the intrinsic pathway.
  • MSM's inhibition of iron metabolism-dependent reactive oxygen species (ROS) generation was crucial for TRAIL-mediated apoptosis induction.
  • MSM modulated p38/p53/ERK signaling and microRNA expression (upregulating miR-130a, downregulating miR-221/222), leading to TRAIL induction.

Conclusions:

  • MSM effectively targets embryonic cancer stem cells (CSCs) by inhibiting iron metabolism.
  • MSM induces apoptosis through the TRAIL-mediated extrinsic pathway, offering a novel therapeutic strategy.
  • MSM demonstrates potential as a neoadjuvant therapy agent for cancer by targeting CSCs and their iron metabolism.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K